5. Mai 2023 – The Pharmacovigilance Risk Assessment Committee (PRAC) – European Medicines Agency’s (EMA’s) safety committee – is reminding healthcare professionals that the use of fluoroquinolone antibiotics, given by mouth, injection, or inhalation, is restricted due to the risk of disabling, long-lasting and potentially irreversible side effects.

For more information, see here.